RECRUITING

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Talk to us

Conditions

AnesthesiaPropofol Adverse ReactionEtomidate Adverse ReactionAnesthesia ComplicationAnesthesia; Adverse EffectAnesthesia; Reactionanesthesiologyadverse drug reactiondrug side effectsedationcardiopulmonaryhemodynamics

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

Official Title

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Quick Facts

Study Start:2022-09-19
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05358535

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult patients (age ≥18 years old)
  2. 2. Having endoscopic procedure at CUH with anesthesia
  3. 3. ASA 3 or above
  4. 4. Ejection Fraction test result available
  1. 1. Known allergies or adverse reactions to study drugs or study drug components or preservatives
  2. 2. Patient refusal
  3. 3. Clinician refusal
  4. 4. Documented cognitive impairments precluding subject ability to consent for themselves unless a surrogate documented legally acceptable decision maker consents for patient participation
  5. 5. Prisoner or incarcerated or patients held by law enforcement officials in custody
  6. 6. Pregnancy or patient refusal for pregnancy testing or screening (standard UTSW policy and protocol requires pregnancy testing for appropriate patients prior to anesthesia)

Contacts and Locations

Study Contact

Christopher Choi
CONTACT
2146486400
christopher.choi@utsouthwestern.edu
Kapil Anand
CONTACT
2146486400
kapil.anand@utsouthwestern.edu

Principal Investigator

Kapil Anand
STUDY_DIRECTOR
University of Texas

Study Locations (Sites)

Clements University Hospital
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Kapil Anand, STUDY_DIRECTOR, University of Texas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-19
Study Completion Date2024-12

Study Record Updates

Study Start Date2022-09-19
Study Completion Date2024-12

Terms related to this study

Keywords Provided by Researchers

  • anesthesia
  • anesthesiology
  • adverse drug reaction
  • drug side effect
  • sedation
  • cardiopulmonary
  • hemodynamics

Additional Relevant MeSH Terms

  • Anesthesia
  • Propofol Adverse Reaction
  • Etomidate Adverse Reaction
  • Anesthesia Complication
  • Anesthesia; Adverse Effect
  • Anesthesia; Reaction